Company Filing History:
1 out of 92 
1 out of 222 
Years Active: 2014
Title: Innovator Spotlight: Chisako Yamauchi
Introduction: Chisako Yamauchi, an accomplished inventor based in Chiba, Japan, has made significant contributions to the field of biomedical innovations, particularly focusing on cancer treatment. With a notable patent to his name, Yamauchi’s work aims to enhance therapeutic strategies for epithelial cancers, addressing critical needs in medical science.
Latest Patents: Chisako Yamauchi holds a patent titled "Treatment method for epithelial cancerous organism." This innovative approach seeks to improve the efficacy of trastuzumab administration, which is often ineffective in certain clinical cases. The patented method includes two steps: first, selectively reducing KLRG1-positive immunocytes ex vivo from the peripheral blood of individuals with epithelial cancer, and second, administering a therapeutic agent that reacts with cancer-specific membrane antigens found in epithelial cancer cells, promoting antibody-dependent cell cytotoxicity. This invention represents a step forward in treating patients with epithelial cancers.
Career Highlights: Throughout his career, Chisako Yamauchi has made notable contributions while working at reputable organizations such as Asahi Kasei Medical Co., Ltd. and the National Cancer Center. His work has been instrumental in developing advanced treatment methodologies that leverage immunological principles.
Collaborations: Yamauchi has had the opportunity to collaborate with distinguished professionals, including Mikitomo Yasutake and Kasumi Ninomiya. These partnerships reflect his commitment to advancing cancer research and treatment through collaborative innovation.
Conclusion: Chisako Yamauchi exemplifies the spirit of innovation, combining scientific knowledge with practical application in the field of cancer treatment. His patent on a novel treatment method underscores the importance of ongoing research and development in healthcare, with the potential to significantly impact clinical outcomes for individuals battling epithelial cancers. As we look forward to more groundbreaking advancements, Yamauchi’s contributions inspire future innovations in the biomedical field.